Ranking results:

Past rankings:

2020
Criterium:	Position:
Overall Score:	> 1000
Total Project Funding per Partner:	> 1000
Total Number of Projects:	> 1000
2019
Criterium:	Position:
Overall Score:	> 1000
Total Project Funding per Partner:	> 1000
Total Number of Projects:	800-900
2018
Criterium:	Position:
Overall Score:	> 1000
Total Project Funding per Partner:	> 1000
Total Number of Projects:	> 1000
Networking Rank (Reputation):	> 1000
2013
Criterium:	Position:
Overall Score:	500-600
Total Project Funding per Partner:	400-500
Total Number of Projects:	69
Total Project Funding:	500-600
Partner Constancy:	58
Project Leadership Index:	69
Diversity Index:	32
2012
Criterium:	Position:
Overall Score:	900-1000
Total Project Funding per Partner:	700-800
Total Number of Projects:	69
Total Project Funding:	> 1000
Networking Rank (Reputation):	> 1000
Networking Rank (Reputation):	> 1000
Partner Constancy:	46
Project Leadership Index:	75
Diversity Index:	60
2010
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000
2009
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 21
As coordinator: 0
As participant: 21
Sole participant: 0
Coordinator / Participant Ratio: 0^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:			Projects [No]:
Year:	coordinator^*	participant^*	per partner	as coordinator	as participant
2022	0	6.348.927	0		1
2021	0	3.917.904	250.905		1
2020	0	18.386.377	736.121		3
2019	0	14.216.203	1.027.933		4
2018	0	3.605.245	247.873		1
2017	0	13.639.764	471.748		3
2013	0	25.111.444	1.796.698		5
2012	0	9.973.404	694.364		2
2010	0	5.851.588	160.889		1

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS	5
KAROLINSKA INSTITUTE	5
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS	4
UNIVERSITY OF GLASGOW	4
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE	3
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER	3
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA	3
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE	3
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD	3
UNIVERSITY OF BERGEN	3
UNIVERSITY OF BIRMINGHAM	3
UNIVERSITY OF OSLO	3
UNIWERSYTET JAGIELLONSKI	3
ACADEMIC MEDICAL CENTRE AMSTERDAM	2
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS	2
CHARITE UNIVERSITAETSMEDIZIN BERLIN	2
EBERHARD KARLS UNIVERSITAET TUEBINGEN	2
EUROPEAN MOLECULAR BIOLOGY LABORATORY	2
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V	2
FUNDACION INSTITUTO DE INVESTIGACION MARQUES DE VALDECILLA	2
GOETEBORGS UNIVERSITET	2
IBM RESEARCH	2
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE	2
INSTITUT DE INVESTIGACIO EN CIENCIES DE LA SALUT GERMANS TRIAS I PUJOL	2
MEDIZINISCHE UNIVERSITAET WIEN	2
OSLO UNIVERSITETSSYKEHUS HF	2
PROTATOUANS ETAIREIA EREYNAS VIOTECHNOLOGIAS MONOPROSOPI ETAIREIA PERIORISMENIS EYTHINIS	2
STICHTING VUMC	2
SYDDANSK UNIVERSITET	2
TEL AVIV UNIVERSITY	2
UNIVERSIDAD POMPEU FABRA	2
UNIVERSITAETSKLINIKUM FREIBURG	2
UNIVERSITAETSKLINIKUM HEIDELBERG	2
UNIVERSITAIR MEDISCH CENTRUM UTRECHT	2
UNIVERSITY OF AARHUS	2
UNIVERSITY OF BOLOGNA	2
UNIVERSITY OF TURKU	2
UPPSALA UNIVERSITET	2
VIB VZW	2
4SC	1
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM	1
ACADEMISCH ZIEKENHUIS GRONINGEN	1
ADJUVATIS	1
AIBILI ASSOCIACAO PARA INVESTIGACAO BIOMEDICA E INNOVACAO EM LUZ E IMAGEM	1
ALEXANDER FLEMING	1
ALFA WASSERMANN	1
ALFASIGMA	1
ALMAZOV FEDERAL HEART BLOOD AND ENDOCRINOLOGY CENTRE FEDERATION AGENCY ON HIGH MEDICAL TECHNOLOGIES	1
ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRL ALTA	1
ALZHEIMER EUROPE	1
AMC MEDICAL RESEARCH BV	1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS	1
ASTON UNIVERSITY	1
AUSTRIAN RESEARCH CENTERS SIEBERDORF	1
AZIENDA OSPEDALIERA CITTA DELLA SALUTE E DELLA SCIENZA DI TORINO	1
AZIENDA OSPEDALIEROUNIVERSITARIA MAGGIORE DELLA CARITA NOVARA	1
BILKENT UNIVERSITESI	1
BIONURE FARMA SL	1
BIOPOLIS SL	1
BIOPREDIC INTERNATIONAL SARL	1
BIOTECTURE	1
BNML BEHAVIORAL & MOLECULAR LAB	1
BYTE FACTORY SYSTEMS SL	1
CABALLERO LLANO CARMELO CESAR	1
CELL STRESS DISCOVERIES LIMITED	1
CENTRE DE REGULACIO GENOMICA	1
CENTRO DE NEUROCIENCIAS E BIOLOGIACELULAR ASSOCIACAO	1
CHARLES RIVER DISCOVERY RESEARCH SERVICES GERMANY	1
CHARLES UNIVERSITY PRAGUE	1
CHEMINOVA AS	1
CHIRACON	1
CLEA TECHNOLOGIES BV	1
CLICLAB TRANSFORMATIVE AGENT SL	1
CLUB FRANCOPHONE DE L'AUTOPHAGIE	1
CONSIGLIO NAZIONALE DELLE RICERCHE	1
CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED MP	1
COST ACTION TRANSAUTOPHAGY	1
DEUTSCHES INSTITUT FUER ERNAEHRUNGSFORSCHUNG	1
DEUTSCHES KREBSFORSCHUNGSZENTRUM	1
EAGLE GENOMICS LIMITED	1
EATRIS ERIC	1
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK	1
ELEVATE BV	1
ELSEVIER BV	1
EMERGENTEC BIODEVELOPMENT	1
EMERSION STUDIO	1
EMULATE INC	1
ENYO PHARMA	1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM	1
ERNSTMORITZARNDTUNIVERSITAET GREIFSWALD	1
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS	1
EUROPEAN CANCER PATIENT COALITION	1
EUROPEAN FOUNDATION FOR THE STUDY OF CHRONIC LIVER FAILURE	1
EUROPEAN LIVER PATIENTS ASSOCIATION	1
FACULDADE DE FARMACIA DA UNIVERSIDADE DE LISBOA	1
FEDERATION INTERNATIONALE DU DIABETE REGION EUROPE AISBL	1
FH OO FORSCHUNGS & ENTWICKLUNGS	1
FIRALIS	1
FOLLOWHEALTH SL	1
FONDAZIONE FATEBENEFRATELLI PER LA RICERCA E LA FORMAZIONE SANITARIA E SOCIALE	1

Constancy:

Total number of partners: 291
Partner loyalty:
Frequent Partner: (> 2 projects): 45
Rare Partner: 246
Frequent / Rare Partner Ratio: 0.18

Project overview:

Start date	Project	acronym	role	funding	partners
2022-12-01	Discovering chronic inflammation biomarkers that define key stages in the Healthy-to-NASH (non-alcoholic steatohepatitis) transition to inform early prevention and treatment strategies	halt-RONIN	participant	6.348.927	23
2021-01-01	Computational Proteomics Training European Innovative Network	PROTrEIN	participant	3.917.904	11
2020-01-01	Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of dementia	RECOGNISED	participant	5.998.273	25
2020-01-01	Development, dIagnostic and prevention of gender-related Somatic and mental COmorbitiEs in iRritable bowel syndrome In Europe	DISCOvERIE	participant	6.000.000	21
2020-01-01	A novel Stratified Medicine Algorithm to predict treatment responses to host-directed therapy in TB patients.	SMA-TB	participant	6.388.104	9
2019-10-01	The life cycle of extracellular vesicles in prostate cancer: from biogenesis and homing, to functional relevance	proEVLifeCycle	participant	2.672.562	10
2019-10-01	Exploitation of the SECRETory pathway for cancer therapy to address European research	SECRET	participant	3.915.872	12
2019-01-01	HEalth data LInkage for ClinicAL benefit	HELICAL	participant	4.050.338	25
2019-01-01	CeLac and European consortium for a personalized medicine approach to Gastric Cancer	LEGACy	participant	3.577.431	11
2018-01-01	COmbatting disorders of adaptive immunity with Systems MedICine	COSMIC	participant	3.605.245	18
2017-11-01	Driving next generation autophagy researchers towards translation	DRIVE	participant	3.890.065	35
2017-01-01	SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS	LIVERHOPE	participant	5.998.800	18
2017-01-01	Training European Network: Metabolic Dysfunctions associated with Pharmacological Treatment of Schizophrenia	TREATMENT	participant	3.750.899	12
2013-11-01	Optimized oxidoreductases for medium and large scale industrial biotransformations	INDOX	participant	7.825.824	15
2013-04-01	"King of hearts, joints and lungs; periodontal pathogens as etiologic factor in RA, CVD and COPD and their impact on treatment strategies."	TRIGGER	participant	5.982.363	11
2013-01-01	Early warning signals of ageing in human stem cells and age-related disorders	SYSTEMAGE	participant	5.989.925	9
2013-01-01	Identifying correlates of protection to accelerate vaccine trials: systems evaluation of two models of experimentally-induced immunity to malaria	SYSMALVAC	participant	2.803.652	7
2013-01-01	A novel drug discovery method based on systems biology: combination therapy and biomarkers for Multiple Sclerosis	COMBIMS	participant	2.509.680	8
2012-09-01	Prolonged inhibition of semaphorine3a pathway via a bio-degradable implant towards a better therapy for visual sensory impairments	VISION	participant	5.661.253	5
2012-04-01	Rheumatoid Arthritis and Periodontal Inflammatory Disease (RAPID)	RAPID	participant	4.312.151	14
2010-11-01	Protein citrullination as a link between periodontal diseases and rheumatoid arthritis (RA) and target for development of novel drugs to treat RA	GUMS AND JOINTS	participant	5.851.588	13

Alias institution names:

ANAXOMICS BIOTECH S L

ANAXOMICS BIOTECH S L - Spain